Literature DB >> 20871673

Centers for medicare & medicaid services: off-label use of colorectal cancer drugs allowed in select clinical trials.

.   

Abstract

Entities:  

Year:  2005        PMID: 20871673      PMCID: PMC2793551          DOI: 10.1200/JOP.2005.1.1.12

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  1 in total

Review 1.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

  1 in total
  2 in total

1.  Developing an effective and compliant plan for billing clinical trials.

Authors:  Lisa R Pitler; Philip D Bonomi
Journal:  J Oncol Pract       Date:  2006-11       Impact factor: 3.840

Review 2.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.